Dashboard
Manage Tickers

IKNAIkena Oncology, Inc.

Nasdaq ikenaoncology.com


$ 1.69 $ 0.01 (0.59 %)    

Monday, 09-Sep-2024 15:59:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 1.7
$ 1.69
$ 1.69 x 100
$ 1.70 x 100
$ 1.69 - $ 1.70
$ 1.02 - $ 4.95
15,755
na
82.04M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-12-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-14-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-ikena-oncology-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Iken...
08/12/2024 10:58:32

HC Wainwright & Co. analyst Andres Maldonado reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $4 price t...

ikena-oncology-q2-2024-eps-028
Ikena Oncology Q2 2024 EPS $(0.28)
08/08/2024 21:21:22

ikena-oncology-discontinues-ik-930-program-and-cuts-workforce-analyst-calls-it-disappointing
Ikena Oncology Discontinues IK-930 Program...
05/29/2024 19:33:17

Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular gl...

why-bank-of-montreal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bank of Montreal Shares Are Trading Lo...
05/29/2024 17:28:35

this-american-airlines-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-wednesday
This American Airlines Analyst Is No Longe...
05/29/2024 14:17:09

wedbush-downgrades-ikena-oncology-to-neutral-lowers-price-target-to-2
Wedbush Downgrades Ikena Oncology to Neutr...
05/29/2024 12:12:28

Wedbush analyst David Nierengarten downgrades Ikena Oncology (NASDAQ:IKNA) from Outperform to Neutral and lowers the price t...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/29/2024 12:06:44

hc-wainwright--co-maintains-buy-on-ikena-oncology-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Ikena...
05/29/2024 10:36:15

HC Wainwright & Co. analyst Andres Maldonado maintains Ikena Oncology (NASDAQ:IKNA) with a Buy and lowers the price targ...

ikena-to-reduce-workforce-by-53
Ikena To Reduce Workforce By ~53%
05/28/2024 20:18:05

ikena-oncology-to-discontinue-development-of-ik-930-is-evaluating-strategic-options-for-co-and-its-development-pipeline
Ikena Oncology To Discontinue Development ...
05/28/2024 20:16:55

wedbush-reiterates-outperform-on-ikena-oncology-maintains-8-price-target
Wedbush Reiterates Outperform on Ikena Onc...
05/14/2024 12:29:03

Wedbush analyst David Nierengarten reiterates Ikena Oncology (NASDAQ:IKNA) with a Outperform and maintains $8 price target.

ikena-oncology-q1-eps-033-beats-041-estimate
Ikena Oncology Q1 EPS $(0.33) Beats $(0.41...
05/13/2024 20:46:45

Ikena Oncology (NASDAQ:IKNA) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.41...

the-analyst-landscape-4-takes-on-ikena-oncology
The Analyst Landscape: 4 Takes On Ikena On...
03/19/2024 12:01:16

hc-wainwright--co-reiterates-buy-on-ikena-oncology-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Iken...
03/19/2024 11:05:21

HC Wainwright & Co. analyst Andres Maldonado reiterates Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $11 price ...

ikena-oncology-q4-earnings-insights
Ikena Oncology: Q4 Earnings Insights
03/12/2024 21:05:08

hc-wainwright--co-maintains-buy-on-ikena-oncology-maintains-11-price-target
HC Wainwright & Co. Maintains Buy on Ikena...
03/12/2024 14:49:23

HC Wainwright & Co. analyst Andres Maldonado maintains Ikena Oncology (NASDAQ:IKNA) with a Buy and maintains $11 price t...

ikena-oncology-q4-eps-041-beats-043-estimate-sales-65800k-miss-314m-estimate
Ikena Oncology Q4 EPS $(0.41) Beats $(0.43...
03/12/2024 12:06:15

Ikena Oncology (NASDAQ:IKNA) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/16/2024 13:06:00

ikena-oncology-refocuses-on-key-programs-analysts-maintain-outperform-ratings-amid-strategic-organizational-changes
Ikena Oncology Refocuses on Key Programs: ...
01/19/2024 19:55:45

Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workf...

wedbush-reiterates-outperform-on-ikena-oncology-maintains-8-price-target
Wedbush Reiterates Outperform on Ikena Onc...
01/19/2024 13:29:27

Wedbush analyst David Nierengarten reiterates Ikena Oncology (NASDAQ:IKNA) with a Outperform and maintains $8 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION